• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PAA 5.56% 17.0¢

PHARMAUST LIMITED - Announcements

PharmAust Limited is a clinical-stage biotechnology company developing therapeutics for... PharmAust Limited is a clinical-stage biotechnology company developing therapeutics for human and animal health applications. The Company’s segments include Corporate and Research. The Company is focused on repurposing monepantel (MPL) for human neurodegenerative diseases. The Company's lead candidate, Monepantel (MPL), is a potent and safe inhibitor of the mTOR pathway, that plays a central role in cell growth and proliferation of cancer cells and in degenerating neurons. The Company is also developing MPL as a treatment for motor neuron disease (MND/ALS), a rare, incurable disease. It is focused on starting Phase II/III clinical study of MPL. It has also completed a Phase II oncology clinical study of MPL in humans and pilot studies in canine cancer. It is also preparing a pivotal monepantel field trial in dogs with B-Cell Lymphoma to enable product registration in the United States.More

Announcements


PAA Mandate signed to raise capital in USA & list on NASDAQ-PAA.AX 02/06/16 download Created with Sketch. 245.49KB
PAA Appendix 4C Quarterly Report & Brief Company Update-PAA.AX PRICE SENSITIVE29/04/16 download Created with Sketch. 521.82KB
PAA RedChip issues research on PharmAust11/03/16 download Created with Sketch. 423.95KB
PAA Strategy for Phase II Clinical Trial of MonepantelPRICE SENSITIVE08/03/16 download Created with Sketch. 229.79KB
PAA Appendix 4D & Half Yearly Report and AccountsPRICE SENSITIVE29/02/16 download Created with Sketch. 610.99KB
PAA PharmAust Featured on The RedChip Money Report on Bloomberg12/02/16 download Created with Sketch. 233.81KB
PAA PharmAust to Present at RedChip Global Online Microcap Conf08/02/16 download Created with Sketch. 315.64KB
PAA Notice of Allowance received from USA Patent OffIcePRICE SENSITIVE05/02/16 download Created with Sketch. 302.87KB
PAA PharmAust Receives $546K R&D Rebate from ATOPRICE SENSITIVE01/02/16 download Created with Sketch. 249.02KB
PAA Appendix 4C - Quarterly Report & Company UpdatePRICE SENSITIVE29/01/16 download Created with Sketch. 462.56KB
PAA USA Roadshow Presentation - January 201618/01/16 download Created with Sketch. 686.5KB
PAA Juniper Pharma Services to reformulate MPL for Phase IIPRICE SENSITIVE11/01/16 download Created with Sketch. 408.28KB
PAA PharmAust Featured on RedChip Money Report on Bloomberg04/01/16 download Created with Sketch. 237.7KB
PAA Epichem Awarded Two Year Contract Extension from DNDiPRICE SENSITIVE21/12/15 download Created with Sketch. 240.64KB
PAA Change of Director's Interest Notice08/12/15 download Created with Sketch. 414.26KB
PAA Appendix 3B & 708 Notice04/12/15 download Created with Sketch. 794.16KB
PAA Change of Director's Interest Notice03/12/15 download Created with Sketch. 413.9KB
PAA Change of Director's Interest Notice02/12/15 download Created with Sketch. 412.04KB
PAA GenScript Further Pre-Clinical Validation for Phase II TrialPRICE SENSITIVE26/11/15 download Created with Sketch. 231.33KB
PAA RedChip appointed to begin Global Investor Relations Program24/11/15 download Created with Sketch. 245.4KB
PAA Change of Director's Interest Notice06/11/15 download Created with Sketch. 413.93KB
PAA Change of Director's Interest Notice05/11/15 download Created with Sketch. 413.58KB
PAA Appendix 3B05/11/15 download Created with Sketch. 751.48KB
PAA Quarterly Report & Company UpdatePRICE SENSITIVE30/10/15 download Created with Sketch. 658.84KB
PAA Consolidation of Capital28/10/15 download Created with Sketch. 124.39KB
PAA Final Director's Interest Notice28/10/15 download Created with Sketch. 311.9KB
PAA Results of Annual General Meeting27/10/15 download Created with Sketch. 93.31KB
PAA PharmAust AGM Presentation 201527/10/15 download Created with Sketch. 2.86MB
PAA Change of Director's Interest Notice22/10/15 download Created with Sketch. 410.18KB
PAA Clinical Trial Report Following Phase I TrialPRICE SENSITIVE21/10/15 download Created with Sketch. 271.77KB
PAA Change of Registered Office & Principal Place of Business19/10/15 download Created with Sketch. 240.76KB
PAA Epichem's New Laboratory Completed29/09/15 download Created with Sketch. 309.45KB
PAA Consolidation/Split - PAAPRICE SENSITIVE22/09/15 download Created with Sketch. 32.84KB
PAA PharmAust Annual Report 201522/09/15 download Created with Sketch. 1.27MB
PAA Notice of Annual General Meeting/Proxy FormPRICE SENSITIVE22/09/15 download Created with Sketch. 432.3KB
PAA Appendix 3B & 708 Notice04/09/15 download Created with Sketch. 792.72KB
PAA Appendix 4E & Full Year Statutory AccountsPRICE SENSITIVE28/08/15 download Created with Sketch. 1.1MB
PAA Appendix 4G & Corporate Governance Statement28/08/15 download Created with Sketch. 614.44KB
PAA Professor Morris plans to retire from PharmAust board24/08/15 download Created with Sketch. 228.28KB
PAA Change of Director's Interest Notice12/08/15 download Created with Sketch. 411.19KB
PAA Clarification on Expiry of Listed Options03/08/15 download Created with Sketch. 73.47KB
PAA Letter to Optionholders03/08/15 download Created with Sketch. 295.88KB
PAA Appendix 4C - Quarterly Report & Company UpdatePRICE SENSITIVE28/07/15 download Created with Sketch. 647.49KB
PAA Phase I Trial at RAH Meets Safety & Cancer Marker End PointsPRICE SENSITIVE23/07/15 download Created with Sketch. 298.28KB
PAA Trading HaltPRICE SENSITIVE22/07/15 download Created with Sketch. 243.78KB
PAA First Two Canines Complete Combination Therapy With PPL-1PRICE SENSITIVE16/07/15 download Created with Sketch. 236.5KB
PAA PharmAust Receives ATO Research & Development RebatePRICE SENSITIVE24/06/15 download Created with Sketch. 246.53KB
PAA PharmAust Initiates Combination Therapy Evaluations in Dogs17/06/15 download Created with Sketch. 237.55KB
PAA Change of registry address12/06/15 download Created with Sketch. 20.69KB
PAA Change of Share Registry Address12/06/15 download Created with Sketch. 20.69KB
PAA Appendix 3B & s708 Notice02/06/15 download Created with Sketch. 873.76KB
PAA Results of Meeting26/05/15 download Created with Sketch. 86.41KB
PAA EGM Shareholder Presentation26/05/15 download Created with Sketch. 433.25KB
PAA Second Dog Shows Suppression of Cancer Marker at Days 3 & 7PRICE SENSITIVE19/05/15 download Created with Sketch. 238.94KB
PAA Reduction of further Cancer Marker confirmed in Human TrialPRICE SENSITIVE11/05/15 download Created with Sketch. 303.76KB
PAA First Dog Shows Suppression of Cancer MarkerPRICE SENSITIVE01/05/15 download Created with Sketch. 237.76KB
PAA Appendix 4C Quarterly Report & Company UpdatePRICE SENSITIVE22/04/15 download Created with Sketch. 602.63KB
PAA Notice of General Meeting/Proxy Form21/04/15 download Created with Sketch. 331.07KB
PAA Approval of Dose Escalation of PPL-1 in Human TrialPRICE SENSITIVE15/04/15 download Created with Sketch. 333.2KB
PAA Modification of Clinical Trial in DogsPRICE SENSITIVE13/04/15 download Created with Sketch. 240.92KB
PAA Lyell McEwin Hospital approved to join PharmAust trialPRICE SENSITIVE08/04/15 download Created with Sketch. 322.01KB
PAA PharmAust Broker Roadshow Presentation - April 201501/04/15 download Created with Sketch. 5.56MB
PAA Joint Patent with Japanese Corporation now publishedPRICE SENSITIVE31/03/15 download Created with Sketch. 230.1KB
PAA Final Patient in Cohort Demonstrates Tumour Marker ReductionPRICE SENSITIVE24/03/15 download Created with Sketch. 260.07KB
PAA Appendix 3B and s708 Notice20/03/15 download Created with Sketch. 878.76KB
PAA PharmAust Shareholder Presentation - March 201519/03/15 download Created with Sketch. 5.62MB
PAA Completion of Lowest Dose Cohort in Human Cancer TrialPRICE SENSITIVE17/03/15 download Created with Sketch. 235.12KB
PAA PharmAust completes $3.14m Share Placement oversubscribedPRICE SENSITIVE16/03/15 download Created with Sketch. 235.96KB
PAA Trading HaltPRICE SENSITIVE12/03/15 download Created with Sketch. 207.65KB
PAA American Assoc for Cancer accepts Late-Breaking Abstract06/03/15 download Created with Sketch. 244.29KB
PAA Second Cancer Patient Completes Course With Stable DiseasePRICE SENSITIVE05/03/15 download Created with Sketch. 250.36KB
PAA Appendix 4D and Half Yearly Report & AccountsPRICE SENSITIVE26/02/15 download Created with Sketch. 563.09KB
PAA Further Update on New Anti-Cancer Drug PPL-1 in Human TrialPRICE SENSITIVE24/02/15 download Created with Sketch. 233.01KB
PAA Human Trial Prelim Results Shows Reduction in Tumour MarkersPRICE SENSITIVE09/02/15 download Created with Sketch. 234.59KB
PAA Clarification to Quarterly Report & Company Update03/02/15 download Created with Sketch. 228.62KB
PAA Appendix 4C - Quarterly Report & Company UpdatePRICE SENSITIVE30/01/15 download Created with Sketch. 610.6KB
PAA Shareholder Update - Human & Canine TrialsPRICE SENSITIVE20/01/15 download Created with Sketch. 232.78KB
PAA Change of Director's Interest Notice08/12/14 download Created with Sketch. 415.1KB
PAA Lowest Dosing Cohort with PPL-1 in Dogs Fully RecruitedPRICE SENSITIVE01/12/14 download Created with Sketch. 238.54KB
PAA Change of Director's Interest Notice26/11/14 download Created with Sketch. 414.43KB
PAA Change of Director's Interest Notice25/11/14 download Created with Sketch. 410.49KB
PAA Change of Director's Interest Notice24/11/14 download Created with Sketch. 414.14KB
PAA Second Patient In Human Cancer Trial Begins Treatment24/11/14 download Created with Sketch. 233.2KB
PAA Research Collaboration & Joint Patent with Japanese CompanyPRICE SENSITIVE18/11/14 download Created with Sketch. 65.7KB
PAA Change of Director's Interest Notice13/11/14 download Created with Sketch. 410.69KB
PAA Approval received to continue with Human Cancer TrialPRICE SENSITIVE10/11/14 download Created with Sketch. 231.2KB
PAA Initial Director's Interest Notice24/10/14 download Created with Sketch. 302.38KB
PAA Results of Annual General Meeting24/10/14 download Created with Sketch. 88.36KB
PAA AGM Shareholder Presentation24/10/14 download Created with Sketch. 7.08MB
PAA First Two Patients in Canine Clinical Trial Begin TreatmentPRICE SENSITIVE22/10/14 download Created with Sketch. 241.63KB
PAA Human Cancer Trial Advancing To Second PatientPRICE SENSITIVE21/10/14 download Created with Sketch. 232.98KB
PAA Appendix 4C Quarterly & Company UpdatePRICE SENSITIVE14/10/14 download Created with Sketch. 599.17KB
PAA Clinical Trial in Dogs is now open for accrualPRICE SENSITIVE02/10/14 download Created with Sketch. 76.44KB
PAA Notice of Annual General Meeting/Proxy Form23/09/14 download Created with Sketch. 129.77KB
PAA Annual Report23/09/14 download Created with Sketch. 2.19MB
PAA Initiation of Clinical Trial in DogsPRICE SENSITIVE09/09/14 download Created with Sketch. 79.3KB
PAA Appendix 4E & Full Year Statutory AccountsPRICE SENSITIVE28/08/14 download Created with Sketch. 1.11MB
PAA Release from escrow - Appendix 3B & Form 60527/08/14 download Created with Sketch. 752.54KB
PAA Human Cancer Trial - First Patient Initiates TreatmentPRICE SENSITIVE07/08/14 download Created with Sketch. 68.6KB
PAA Appendix 4C - Quarterly Report & Company UpdatePRICE SENSITIVE25/07/14 download Created with Sketch. 613.61KB
PAA Mandate signed to raise capital in USA & list on NASDAQ-PAA.AX
02/06/16 download Created with Sketch. 245.49KB
PAA Appendix 4C Quarterly Report & Brief Company Update-PAA.AX
29/04/16PRICE SENSITIVE download Created with Sketch. 521.82KB
PAA RedChip issues research on PharmAust
11/03/16 download Created with Sketch. 423.95KB
PAA Strategy for Phase II Clinical Trial of Monepantel
08/03/16PRICE SENSITIVE download Created with Sketch. 229.79KB
PAA Appendix 4D & Half Yearly Report and Accounts
29/02/16PRICE SENSITIVE download Created with Sketch. 610.99KB
PAA PharmAust Featured on The RedChip Money Report on Bloomberg
12/02/16 download Created with Sketch. 233.81KB
PAA PharmAust to Present at RedChip Global Online Microcap Conf
08/02/16 download Created with Sketch. 315.64KB
PAA Notice of Allowance received from USA Patent OffIce
05/02/16PRICE SENSITIVE download Created with Sketch. 302.87KB
PAA PharmAust Receives $546K R&D Rebate from ATO
01/02/16PRICE SENSITIVE download Created with Sketch. 249.02KB
PAA Appendix 4C - Quarterly Report & Company Update
29/01/16PRICE SENSITIVE download Created with Sketch. 462.56KB
PAA USA Roadshow Presentation - January 2016
18/01/16 download Created with Sketch. 686.5KB
PAA Juniper Pharma Services to reformulate MPL for Phase II
11/01/16PRICE SENSITIVE download Created with Sketch. 408.28KB
PAA PharmAust Featured on RedChip Money Report on Bloomberg
04/01/16 download Created with Sketch. 237.7KB
PAA Epichem Awarded Two Year Contract Extension from DNDi
21/12/15PRICE SENSITIVE download Created with Sketch. 240.64KB
PAA Change of Director's Interest Notice
08/12/15 download Created with Sketch. 414.26KB
PAA Appendix 3B & 708 Notice
04/12/15 download Created with Sketch. 794.16KB
PAA Change of Director's Interest Notice
03/12/15 download Created with Sketch. 413.9KB
PAA Change of Director's Interest Notice
02/12/15 download Created with Sketch. 412.04KB
PAA GenScript Further Pre-Clinical Validation for Phase II Trial
26/11/15PRICE SENSITIVE download Created with Sketch. 231.33KB
PAA RedChip appointed to begin Global Investor Relations Program
24/11/15 download Created with Sketch. 245.4KB
PAA Change of Director's Interest Notice
06/11/15 download Created with Sketch. 413.93KB
PAA Change of Director's Interest Notice
05/11/15 download Created with Sketch. 413.58KB
PAA Appendix 3B
05/11/15 download Created with Sketch. 751.48KB
PAA Quarterly Report & Company Update
30/10/15PRICE SENSITIVE download Created with Sketch. 658.84KB
PAA Consolidation of Capital
28/10/15 download Created with Sketch. 124.39KB
PAA Final Director's Interest Notice
28/10/15 download Created with Sketch. 311.9KB
PAA Results of Annual General Meeting
27/10/15 download Created with Sketch. 93.31KB
PAA PharmAust AGM Presentation 2015
27/10/15 download Created with Sketch. 2.86MB
PAA Change of Director's Interest Notice
22/10/15 download Created with Sketch. 410.18KB
PAA Clinical Trial Report Following Phase I Trial
21/10/15PRICE SENSITIVE download Created with Sketch. 271.77KB
PAA Change of Registered Office & Principal Place of Business
19/10/15 download Created with Sketch. 240.76KB
PAA Epichem's New Laboratory Completed
29/09/15 download Created with Sketch. 309.45KB
PAA Consolidation/Split - PAA
22/09/15PRICE SENSITIVE download Created with Sketch. 32.84KB
PAA PharmAust Annual Report 2015
22/09/15 download Created with Sketch. 1.27MB
PAA Notice of Annual General Meeting/Proxy Form
22/09/15PRICE SENSITIVE download Created with Sketch. 432.3KB
PAA Appendix 3B & 708 Notice
04/09/15 download Created with Sketch. 792.72KB
PAA Appendix 4E & Full Year Statutory Accounts
28/08/15PRICE SENSITIVE download Created with Sketch. 1.1MB
PAA Appendix 4G & Corporate Governance Statement
28/08/15 download Created with Sketch. 614.44KB
PAA Professor Morris plans to retire from PharmAust board
24/08/15 download Created with Sketch. 228.28KB
PAA Change of Director's Interest Notice
12/08/15 download Created with Sketch. 411.19KB
PAA Clarification on Expiry of Listed Options
03/08/15 download Created with Sketch. 73.47KB
PAA Letter to Optionholders
03/08/15 download Created with Sketch. 295.88KB
PAA Appendix 4C - Quarterly Report & Company Update
28/07/15PRICE SENSITIVE download Created with Sketch. 647.49KB
PAA Phase I Trial at RAH Meets Safety & Cancer Marker End Points
23/07/15PRICE SENSITIVE download Created with Sketch. 298.28KB
PAA Trading Halt
22/07/15PRICE SENSITIVE download Created with Sketch. 243.78KB
PAA First Two Canines Complete Combination Therapy With PPL-1
16/07/15PRICE SENSITIVE download Created with Sketch. 236.5KB
PAA PharmAust Receives ATO Research & Development Rebate
24/06/15PRICE SENSITIVE download Created with Sketch. 246.53KB
PAA PharmAust Initiates Combination Therapy Evaluations in Dogs
17/06/15 download Created with Sketch. 237.55KB
PAA Change of registry address
12/06/15 download Created with Sketch. 20.69KB
PAA Change of Share Registry Address
12/06/15 download Created with Sketch. 20.69KB
PAA Appendix 3B & s708 Notice
02/06/15 download Created with Sketch. 873.76KB
PAA Results of Meeting
26/05/15 download Created with Sketch. 86.41KB
PAA EGM Shareholder Presentation
26/05/15 download Created with Sketch. 433.25KB
PAA Second Dog Shows Suppression of Cancer Marker at Days 3 & 7
19/05/15PRICE SENSITIVE download Created with Sketch. 238.94KB
PAA Reduction of further Cancer Marker confirmed in Human Trial
11/05/15PRICE SENSITIVE download Created with Sketch. 303.76KB
PAA First Dog Shows Suppression of Cancer Marker
01/05/15PRICE SENSITIVE download Created with Sketch. 237.76KB
PAA Appendix 4C Quarterly Report & Company Update
22/04/15PRICE SENSITIVE download Created with Sketch. 602.63KB
PAA Notice of General Meeting/Proxy Form
21/04/15 download Created with Sketch. 331.07KB
PAA Approval of Dose Escalation of PPL-1 in Human Trial
15/04/15PRICE SENSITIVE download Created with Sketch. 333.2KB
PAA Modification of Clinical Trial in Dogs
13/04/15PRICE SENSITIVE download Created with Sketch. 240.92KB
PAA Lyell McEwin Hospital approved to join PharmAust trial
08/04/15PRICE SENSITIVE download Created with Sketch. 322.01KB
PAA PharmAust Broker Roadshow Presentation - April 2015
01/04/15 download Created with Sketch. 5.56MB
PAA Joint Patent with Japanese Corporation now published
31/03/15PRICE SENSITIVE download Created with Sketch. 230.1KB
PAA Final Patient in Cohort Demonstrates Tumour Marker Reduction
24/03/15PRICE SENSITIVE download Created with Sketch. 260.07KB
PAA Appendix 3B and s708 Notice
20/03/15 download Created with Sketch. 878.76KB
PAA PharmAust Shareholder Presentation - March 2015
19/03/15 download Created with Sketch. 5.62MB
PAA Completion of Lowest Dose Cohort in Human Cancer Trial
17/03/15PRICE SENSITIVE download Created with Sketch. 235.12KB
PAA PharmAust completes $3.14m Share Placement oversubscribed
16/03/15PRICE SENSITIVE download Created with Sketch. 235.96KB
PAA Trading Halt
12/03/15PRICE SENSITIVE download Created with Sketch. 207.65KB
PAA American Assoc for Cancer accepts Late-Breaking Abstract
06/03/15 download Created with Sketch. 244.29KB
PAA Second Cancer Patient Completes Course With Stable Disease
05/03/15PRICE SENSITIVE download Created with Sketch. 250.36KB
PAA Appendix 4D and Half Yearly Report & Accounts
26/02/15PRICE SENSITIVE download Created with Sketch. 563.09KB
PAA Further Update on New Anti-Cancer Drug PPL-1 in Human Trial
24/02/15PRICE SENSITIVE download Created with Sketch. 233.01KB
PAA Human Trial Prelim Results Shows Reduction in Tumour Markers
09/02/15PRICE SENSITIVE download Created with Sketch. 234.59KB
PAA Clarification to Quarterly Report & Company Update
03/02/15 download Created with Sketch. 228.62KB
PAA Appendix 4C - Quarterly Report & Company Update
30/01/15PRICE SENSITIVE download Created with Sketch. 610.6KB
PAA Shareholder Update - Human & Canine Trials
20/01/15PRICE SENSITIVE download Created with Sketch. 232.78KB
PAA Change of Director's Interest Notice
08/12/14 download Created with Sketch. 415.1KB
PAA Lowest Dosing Cohort with PPL-1 in Dogs Fully Recruited
01/12/14PRICE SENSITIVE download Created with Sketch. 238.54KB
PAA Change of Director's Interest Notice
26/11/14 download Created with Sketch. 414.43KB
PAA Change of Director's Interest Notice
25/11/14 download Created with Sketch. 410.49KB
PAA Change of Director's Interest Notice
24/11/14 download Created with Sketch. 414.14KB
PAA Second Patient In Human Cancer Trial Begins Treatment
24/11/14 download Created with Sketch. 233.2KB
PAA Research Collaboration & Joint Patent with Japanese Company
18/11/14PRICE SENSITIVE download Created with Sketch. 65.7KB
PAA Change of Director's Interest Notice
13/11/14 download Created with Sketch. 410.69KB
PAA Approval received to continue with Human Cancer Trial
10/11/14PRICE SENSITIVE download Created with Sketch. 231.2KB
PAA Initial Director's Interest Notice
24/10/14 download Created with Sketch. 302.38KB
PAA Results of Annual General Meeting
24/10/14 download Created with Sketch. 88.36KB
PAA AGM Shareholder Presentation
24/10/14 download Created with Sketch. 7.08MB
PAA First Two Patients in Canine Clinical Trial Begin Treatment
22/10/14PRICE SENSITIVE download Created with Sketch. 241.63KB
PAA Human Cancer Trial Advancing To Second Patient
21/10/14PRICE SENSITIVE download Created with Sketch. 232.98KB
PAA Appendix 4C Quarterly & Company Update
14/10/14PRICE SENSITIVE download Created with Sketch. 599.17KB
PAA Clinical Trial in Dogs is now open for accrual
02/10/14PRICE SENSITIVE download Created with Sketch. 76.44KB
PAA Notice of Annual General Meeting/Proxy Form
23/09/14 download Created with Sketch. 129.77KB
PAA Annual Report
23/09/14 download Created with Sketch. 2.19MB
PAA Initiation of Clinical Trial in Dogs
09/09/14PRICE SENSITIVE download Created with Sketch. 79.3KB
PAA Appendix 4E & Full Year Statutory Accounts
28/08/14PRICE SENSITIVE download Created with Sketch. 1.11MB
PAA Release from escrow - Appendix 3B & Form 605
27/08/14 download Created with Sketch. 752.54KB
PAA Human Cancer Trial - First Patient Initiates Treatment
07/08/14PRICE SENSITIVE download Created with Sketch. 68.6KB
PAA Appendix 4C - Quarterly Report & Company Update
25/07/14PRICE SENSITIVE download Created with Sketch. 613.61KB
(20min delay)
Last
17.0¢
Change
-0.010(5.56%)
Mkt cap ! $67.30M
Open High Low Value Volume
17.5¢ 18.0¢ 16.3¢ $581.7K 3.408M

Buyers (Bids)

No. Vol. Price($)
4 502428 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 40529 1
View Market Depth
Last trade - 16.10pm 10/05/2024 (20 minute delay) ?
Last
17.5¢
  Change
-0.010 ( 3.15 %)
Open High Low Volume
17.5¢ 18.0¢ 16.0¢ 3492891
Last updated 15.59pm 10/05/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.